SAFETY OF USTEKINUMAB IN IBD: FINAL POOLED LONG-TERM SAFETY ANALYSIS THROUGH 5 YEARS IN CD AND 4 YEARS IN UC

被引：0
|
作者：
Sands, Bruce E.
Feagan, Brian G.
Ott, Elyssa
Gasink, Christopher
Marano, Colleen W.
Miao, Ye
Sandborn, William J.
Danese, Silvio
Abreu, Maria T.
Ghosh, Subrata
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1743
引用
收藏
页码：S889 / S889
页数：1
相关论文
共 50 条
  • [31] Safety of Ustekinumab Across Approved Adult Indications: Pooled Safety Analysis in Crohn's Disease, Ulcerative Colitis, Psoriasis, and Psoriatic Arthritis Through up to 5 Years
    Long, Millie D.
    Danese, Silvio
    Ott, Elyssa
    Gasink, Christopher
    Miao, Ye
    Baker, Thomas
    Tikhonov, Ilia
    Rahman, Proton
    Strober, Bruce
    Loftus, Edward V.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S440 - S440
  • [32] LONG-TERM SAFETY OF TG-C: ANALYSIS OF SAFETY DATA OVER 15 YEARS
    Hunter, David
    Wang, Martin
    Kim, Sun Jin
    Han, Sungsu
    Noh, Moon Jong
    OSTEOARTHRITIS AND CARTILAGE, 2024, 32 : S206 - S207
  • [33] Long-Term Efficacy and Safety of Photoselective Vaporization of the Prostate: Results at 5 Years
    Nomura, H.
    Yamaguchi, A.
    Seki, N.
    Naito, S.
    UROLOGY, 2012, 80 (03) : S226 - S227
  • [34] Long-term safety of oxcarbazepine in patients 1 month to <17 years of age with partial seizures:: A pooled analysis
    Sturm, Y
    Stites, T
    Qian, C
    EPILEPSIA, 2005, 46 : 119 - 119
  • [35] LONG-TERM SAFETY OF RITUXIMAB: POOLED ANALYSIS OF THE RHEUMATOID ARTHRITIS GLOBAL CLINICAL TRIAL PROGRAMME OVER 11 YEARS
    van Vollenhoven, R. F.
    Emery, P.
    Bingham, C. O.
    Keystone, E.
    Fleischmann, R. M.
    Furst, D.
    Hessey, E. W.
    Vashishtha, A.
    Mehbob, A.
    Lehane, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 625 - 626
  • [36] Long-Term Safety Of Rituximab: Pooled Analysis Of The Rheumatoid Arthritis Global Clinical Trial Program Over 11 Years
    van Vollenhoven, Ronald
    Emery, Paul
    Bingham, Clifton O., III
    Keystone, Edward
    Fleischmann, Roy M.
    Furst, Daniel E.
    Hessey, Eva W.
    Mehbob, Abdul
    Lehane, Patricia B.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1000 - S1000
  • [37] LONG-TERM SAFETY OF RITUXIMAB: POOLED ANALYSIS OF THE RHEUMATOID ARTHRITIS GLOBAL CLINICAL TRIAL PROGRAMME OVER 11 YEARS
    van Vollenhoven, Ronald F.
    Emery, Paul
    Bingham, Clifton O., III
    Keystone, Edward
    Fleischmann, Roy M.
    Furst, Daniel E.
    Hessey, Eva W.
    Mehbob, Abdul
    Lehane, Patricia B.
    RHEUMATOLOGY, 2014, 53 : 97 - 98
  • [38] Long-Term Safety of Rituximab in Rheumatoid Arthritis: Pooled Analysis of Patients in Clinical Trials with up to 9.5 Years of Treatment
    van Vollenhoven, Ronald F.
    Emery, Paul
    Bingham, Clifton O.
    Keystone, Edward
    Fleischmann, Roy M.
    Furst, Daniel E.
    Tyson, Nicola
    Collinson, Neil
    Lehane, Patricia B.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S857 - S857
  • [39] Pooled Safety Analysis of Long-term MMX® Mesalamine Administration
    Solomon, Dory
    Paridaens, Kristine
    Palmen, Mary
    Barrett, Karen
    Streck, Paul
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S25 - S25
  • [40] Efficacy and Safety of Ustekinumab for Crohn's Disease: Results From IM-UNITI Long-Term Extension Through 3 Years
    Sandborn, William J.
    Rutgeerts, Paul
    Jacobstein, Douglas
    Gasink, Christopher
    Patel, Reese
    Zou, Bin
    Johanns, Jewel
    Sands, Bruce E.
    Hanauer, Stephen
    Targan, Stephan
    Ghosh, Subrata
    de Villiers, Willem
    Colombel, Jean-Frederic
    Feagan, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S345 - S346
12345